584 related articles for article (PubMed ID: 31084347)
1. Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.
Payabvash S; Chan A; Jabehdar Maralani P; Malhotra A
Neuroradiol J; 2019 Aug; 32(4):232-240. PubMed ID: 31084347
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma.
Ravanelli M; Grammatica A; Tononcelli E; Morello R; Leali M; Battocchio S; Agazzi GM; Buglione di Monale E Bastia M; Maroldi R; Nicolai P; Farina D
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1878-1883. PubMed ID: 30213805
[TBL] [Abstract][Full Text] [Related]
3. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas.
Driessen JP; van Bemmel AJ; van Kempen PM; Janssen LM; Terhaard CH; Pameijer FA; Willems SM; Stegeman I; Grolman W; Philippens ME
Head Neck; 2016 Apr; 38 Suppl 1():E613-8. PubMed ID: 25783872
[TBL] [Abstract][Full Text] [Related]
4. Intravoxel incoherent motion diffusion-weighted imaging for oropharyngeal squamous cell carcinoma: Correlation with human papillomavirus Status.
Vidiri A; Marzi S; Gangemi E; Benevolo M; Rollo F; Farneti A; Marucci L; Spasiano F; Sperati F; Di Giuliano F; Pellini R; Sanguineti G
Eur J Radiol; 2019 Oct; 119():108640. PubMed ID: 31442928
[TBL] [Abstract][Full Text] [Related]
5. Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.
de Perrot T; Lenoir V; Domingo Ayllón M; Dulguerov N; Pusztaszeri M; Becker M
AJNR Am J Neuroradiol; 2017 Nov; 38(11):2153-2160. PubMed ID: 28912282
[TBL] [Abstract][Full Text] [Related]
6. The ability of post-chemoradiotherapy DWI ADC
Connor S; Sit C; Anjari M; Lei M; Guerrero-Urbano T; Szyszko T; Cook G; Bassett P; Goh V
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2323-2336. PubMed ID: 34159420
[TBL] [Abstract][Full Text] [Related]
7. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.
Ravanelli M; Grammatica A; Maddalo M; Ramanzin M; Agazzi GM; Tononcelli E; Battocchio S; Bossi P; Vezzoli M; Maroldi R; Farina D
AJNR Am J Neuroradiol; 2020 Aug; 41(8):1473-1479. PubMed ID: 32732272
[TBL] [Abstract][Full Text] [Related]
9. The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient.
Connor S; Anjari M; Burd C; Guha A; Lei M; Guerrero-Urbano T; Pai I; Bassett P; Goh V
Br J Radiol; 2022 Feb; 95(1130):20210333. PubMed ID: 34111977
[TBL] [Abstract][Full Text] [Related]
10. Cell-Free Human Papillomavirus-DNA for Monitoring Treatment Response of Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
Campo F; Zocchi J; Moretto S; Mazzola F; Petruzzi G; Donà MG; Benevolo M; Iocca O; De Virgilio A; Pichi B; Manciocco V; Pellini R
Laryngoscope; 2022 Mar; 132(3):560-568. PubMed ID: 34236084
[TBL] [Abstract][Full Text] [Related]
11. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
Front Immunol; 2021; 12():645170. PubMed ID: 33897693
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and clinicopathological correlation of human papillomavirus in head and neck squamous cell carcinoma in India: A systematic review article.
Nandi S; Mandal A; Chhebbi M
Cancer Treat Res Commun; 2021; 26():100301. PubMed ID: 33401132
[TBL] [Abstract][Full Text] [Related]
13. The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature.
Flach S; Maniam P; Hey SY; Manickavasagam J
Clin Otolaryngol; 2024 Jul; 49(4):384-403. PubMed ID: 38658385
[TBL] [Abstract][Full Text] [Related]
14. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
[TBL] [Abstract][Full Text] [Related]
15. HPV-associated head and neck cancers in the Asia Pacific: A critical literature review & meta-analysis.
Shaikh MH; McMillan NA; Johnson NW
Cancer Epidemiol; 2015 Dec; 39(6):923-38. PubMed ID: 26523982
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Chung SR; Choi YJ; Suh CH; Lee JH; Baek JH
Korean J Radiol; 2019 Apr; 20(4):649-661. PubMed ID: 30887747
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-Weighted Imaging to Assess HPV-Positive versus HPV-Negative Oropharyngeal Squamous Cell Carcinoma: The Importance of b-Values.
Lenoir V; Delattre BMA; M'RaD Y; De Vito C; de Perrot T; Becker M
AJNR Am J Neuroradiol; 2022 Jun; 43(6):905-912. PubMed ID: 35618419
[TBL] [Abstract][Full Text] [Related]
18. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
[TBL] [Abstract][Full Text] [Related]
19. Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study.
Barlow J; Gilja S; Ferrandino RM; Berger MH; Posner MR; Bakst RL; Khan MN; Teng MS; Genden EM; Chai RL; Roof SA
Am J Otolaryngol; 2024; 45(3):104243. PubMed ID: 38442460
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
